scholarly journals Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study

The Breast ◽  
2016 ◽  
Vol 29 ◽  
pp. 102-108 ◽  
Author(s):  
An De Groef ◽  
Marijke Van Kampen ◽  
Elena Tieto ◽  
Petra Schönweger ◽  
Marie-Rose Christiaens ◽  
...  
2005 ◽  
Vol 31 (3) ◽  
pp. 221-225 ◽  
Author(s):  
M.C. Kokke ◽  
I. Jannink ◽  
P.C. Barneveld ◽  
J.C. van der Linden ◽  
W.A.H. Gelderman ◽  
...  

2021 ◽  
pp. 1-16
Author(s):  
Michelle Teodoro Alves ◽  
Ricardo Simões ◽  
Rodrigo Mendonça Cardoso Pestana ◽  
Angélica Navarro de Oliveira ◽  
Heloísa Helena Marques Oliveira ◽  
...  

2008 ◽  
Vol 108 (2) ◽  
pp. 203-207 ◽  
Author(s):  
E.M. Heuts ◽  
F.W.C. van der Ent ◽  
K.W.E. Hulsewé ◽  
P.A.M. Heeren ◽  
A.G.M. Hoofwijk

2006 ◽  
Vol 32 (3) ◽  
pp. 282-286 ◽  
Author(s):  
A.Y. de Kanter ◽  
M.M. Menke-Pluymers ◽  
M.W.J.M. Wouters ◽  
I. Burgmans ◽  
A.N. van Geel ◽  
...  

2000 ◽  
Vol 15 (2) ◽  
pp. 135-138 ◽  
Author(s):  
J.-L. Floiras ◽  
K. Hacene ◽  
F. Turpin ◽  
F. Spyratos

The impact of ER levels on the response to tamoxifen was evaluated in 1,623 postmenopausal primary breast cancer patients treated at our center (median follow-up 8.2 years). In patients receiving adjuvant tamoxifen a significantly longer disease-free survival (DFS) was observed when ER levels were elevated (p<0.00001). Very high ER (>424 fmol/mg protein) appeared to be detrimental in node-negative patients not treated with tamoxifen.


Sign in / Sign up

Export Citation Format

Share Document